These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

914 related items for PubMed ID: 8027577

  • 21. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK.
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [Abstract] [Full Text] [Related]

  • 22. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S, Sugaya M, Nakajima R, Oka T, Takahashi N, Kabasawa M, Miyagaki T, Asano Y, Sato S.
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [Abstract] [Full Text] [Related]

  • 23. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
    Johno M, Ono T.
    Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
    [Abstract] [Full Text] [Related]

  • 24. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ, Moerman-Herzog A, Wong HK.
    BMC Cancer; 2021 May 03; 21(1):492. PubMed ID: 33941102
    [Abstract] [Full Text] [Related]

  • 25. Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.
    Showe LC, Fox FE, Williams D, Au K, Niu Z, Rook AH.
    J Immunol; 1999 Oct 01; 163(7):4073-9. PubMed ID: 10491012
    [Abstract] [Full Text] [Related]

  • 26. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA.
    Horwitz DA, Wang H, Gray JD.
    Lupus; 1994 Oct 01; 3(5):423-8. PubMed ID: 7841998
    [Abstract] [Full Text] [Related]

  • 27. [Mycosis fungoides and Sézary syndrome : a systematic review].
    André F, Guenova E, Blanchard G.
    Rev Med Suisse; 2022 Mar 30; 18(775):578-589. PubMed ID: 35353453
    [Abstract] [Full Text] [Related]

  • 28. Mycosis fungoides and Sézary's syndrome show distinct histomorphological features.
    Imai S, Burg G, Braun-Falco O.
    Dermatologica; 1986 Mar 30; 173(3):131-5. PubMed ID: 3770259
    [Abstract] [Full Text] [Related]

  • 29. Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome.
    Hofman FM, Meyer PR, Yanagihara E, Modlin RL, Rea TH, Parker JW, Lukes RJ, Taylor CR.
    Am J Dermatopathol; 1983 Apr 30; 5(2):135-43. PubMed ID: 6224436
    [Abstract] [Full Text] [Related]

  • 30. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B, Zain J, Rosen ST, Querfeld C.
    Curr Opin Oncol; 2016 Jan 30; 28(1):88-96. PubMed ID: 26632770
    [Abstract] [Full Text] [Related]

  • 31. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM, Cerroni L.
    Am J Dermatopathol; 2015 Feb 30; 37(2):115-21. PubMed ID: 25406852
    [Abstract] [Full Text] [Related]

  • 32. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L, Rocas D, Dalle S, Sako N, Pelletier L, Martin N, Dupuy A, Tazi N, Balme B, Vergier B, Beylot-Barry M, Carlotti A, Bagot M, Battistella M, Chaby G, Ingen-Housz-Oro S, Gaulard P, Ortonne N.
    Br J Dermatol; 2022 Dec 30; 187(6):970-980. PubMed ID: 35895386
    [Abstract] [Full Text] [Related]

  • 33. Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gamma.
    Dummer R, Sigg-Zemann S, Kalthof K, Muletta S, Meyer JC, Burg G.
    Dermatology; 1994 Dec 30; 189(2):120-4. PubMed ID: 7915555
    [Abstract] [Full Text] [Related]

  • 34. T cell subset heterogeneity in a series of patients with mycosis fungoides and Sézary syndrome.
    Piepkorn M, Marty J, Kjeldsberg CR.
    J Am Acad Dermatol; 1984 Sep 30; 11(3):427-32. PubMed ID: 6237132
    [Abstract] [Full Text] [Related]

  • 35. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
    Cetinözman F, Jansen PM, Vermeer MH, Willemze R.
    Arch Dermatol; 2012 Dec 30; 148(12):1379-85. PubMed ID: 23247480
    [Abstract] [Full Text] [Related]

  • 36. Mycosis fungoides and the Sézary syndrome.
    Kim YH, Hoppe RT.
    Semin Oncol; 1999 Jun 30; 26(3):276-89. PubMed ID: 10375085
    [Abstract] [Full Text] [Related]

  • 37. Diminished CD3 expression is useful for detecting and enumerating Sézary cells.
    Edelman J, Meyerson HJ.
    Am J Clin Pathol; 2000 Sep 30; 114(3):467-77. PubMed ID: 10989648
    [Abstract] [Full Text] [Related]

  • 38. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
    Brender C, Nielsen M, Kaltoft K, Mikkelsen G, Zhang Q, Wasik M, Billestrup N, Odum N.
    Blood; 2001 Feb 15; 97(4):1056-62. PubMed ID: 11159537
    [Abstract] [Full Text] [Related]

  • 39. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK, Cassin M, Lessin SR, Rook AH.
    J Am Acad Dermatol; 2001 Aug 15; 45(2):208-16. PubMed ID: 11464181
    [Abstract] [Full Text] [Related]

  • 40. Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis.
    Wada DA, Wilcox RA, Weenig RH, Gibson LE.
    J Cutan Pathol; 2010 May 15; 37(5):535-41. PubMed ID: 19674197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.